leiomyosarcoma of the maxilla

Clicks: 236
ID: 200158
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #18 of 19 articles by views in aids care

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Leiomyosarcomas (LMSs) are relatively uncommon mesenchymal neoplasms of smooth muscle differentiation. Only 1% of the lesions occur in the head and neck region. Surgical excision with radiotherapy and chemotherapy is the most commonly executed procedure for recurrent and metastatic tumors. We report a rare LMS case of the maxilla, defined in a 19-year-old male patient. Following the diagnosis of a malignant neoplasm on frozen section, wide resection, with a 1 cm clear margin, was performed. The lesion was then sent for histopathological examination. Spindle cell malignancy was found in histopathological sections of the lesion, histologically consistent with LMS. A radiographical evaluation, magnetic resonance imaging, computerized tomography, and positron emission tomography were performed to detect metastasis. Signs of local recurrence or distant metastasis were not noted at the 12-month follow-up following the definitive surgical procedure.
Reference Key
bayramoglu2018journalleiomyosarcoma Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal aids care
Year 2018
DOI
10.4103/jorr.jorr_34_17
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.